Cited by 724Cancer-related Molecular PathwaysUbiquitin and proteasome pathwaysHeat shock proteins research

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53

Open access

Honda, Reiko, Yasuda, Hideyo·1999·The EMBO Journal

Open this paper in CoChat — free account Open PDF

Abstract

We have demonstrated previously that the oncoprotein Mdm2 has a ubiquitin ligase activity for the tumor suppressor p53 protein. In the present study, we characterize this ubiquitin ligase activity of Mdm2. We first demonstrate the ubiquitination of several p53 point mutants and deletion mutants by Mdm2. The point mutants, which cannot bind to Mdm2, are not ubiquitinated by Mdm2. The ubiquitination of the C-terminal deletion mutants, which contain so-called Mdm2-binding sites, is markedly decreased, compared with that of wild-type p53. The binding of Mdm2 to p53 is essential for ubiquitination, but p53's tertiary structure and/or C-terminal region may also be important for this reaction. DNA-dependent protein kinase is known to phosphorylate p53 on Mdm2-binding sites, where DNA damage induces phosphorylation, and p53 phosphorylated by this kinase is not a good substrate for Mdm2. This suggests that DNA damage-induced phosphorylation stabilizes p53 by inhibiting its ubiquitination by Mdm2. We further investigated whether the tumor suppressor p19(ARF) affects the ubiquitin ligase activity of Mdm2 for p53. The activity of p19(ARF)-bound Mdm2 was found to be lower than that of free Mdm2, suggesting that p19(ARF) promotes the stabilization of p53 by inactivating Mdm2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/emboj/18.1.22

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“When Mdm2 cDNA is transfected into human cells, p53 degradation is accelerated (Haupt et al., 1997; Kubbutat et al., 1997).”
Background
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,416
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042

Flagged first, then by citations

Show all 43 references

Sorted by citations

Items 101–200 of 721

Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformation
Damalas, A., Kahan, S., Shtutman, M. S., Ben‐Ze'ev, A., & Oren, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4912 · Cited by 208
MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation
Jin, Y., Lee, H., Zeng, S. X., Dai, M., & Lu, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg600 · Cited by 206
p53 Signaling and Cell Cycle Checkpoints
Stewart, Z. A., & Pietenpol, J. A. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000199t · Cited by 204
Tyrosine phosphorylation of Mdm2 by c‐Abl: implications for p53 regulation
Goldberg, Z., Sionov, R. V., Berger, M., Zwang, Y., Perets, R., Etten, R. A. V., Oren, M., Taya, Y., & Haupt, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf384 · Cited by 200
Role of T antigen interactions with p53 in tumorigenesis
Pipas, J. M., & Levine, A. J. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0343 · Cited by 204
Multiple Lysine Mutations in the C-Terminal Domain of p53 Interfere with MDM2-Dependent Protein Degradation and Ubiquitination
Nakamura, S., Roth, J. A., & Mukhopadhyay, T. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9391-9398.2000 · Cited by 198
MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins
Kobet, E., Zeng, X., Zhu, Y., Keller, D., & Lu, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12547 · Cited by 193
Gain-of-function mutations in the tumor suppressor gene p53.
van Oijen, M. G., & Slootweg, P. J. (2000) · PubMed · Cited by 193
Ras proteins in the control of the cell cycle and cell differentiation
Crespo, P., & León, J. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000645 · Cited by 190
Identification of a cryptic nucleolar-localization signal in MDM2
Lohrum, M. A. E., Ashcroft, M. A., Kubbutat, M. H. G., & Vousden, K. H. (2000) · Nature Cell Biology · doi:10.1038/35004057 · Cited by 186
The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex
Gmachl, M., Gieffers, C., Podtelejnikov, A. V., Mann, M., & Peters, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8973 · Cited by 185
Enhanced Mdm2 activity inhibits pRB function via ubiquitin‐dependent degradation
Uchida, C., Miwa, S., Kitagawa, K., Hattori, T., Isobe, T., Otani, S., Oda, T., Sugimura, H., Kamijo, T., Ookawa, K., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600486 · Cited by 191
Self-citation
Inhibition of MDM2 by hsp90 Contributes to Mutant p53 Stabilization
Peng, Y., Chen, L., Li, C., Lu, W., & Chen, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102817200 · Cited by 180
Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis
Eischen, C. M., Roussel, M. F., Korsmeyer, S. J., & Cleveland, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7653-7662.2001 · Cited by 186
Regulation of p53 stability and activity in response to genotoxic stress
Colman, M. S., Afshari, C. A., & Barrett, J. C. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00035-1 · Cited by 182
Regulating the p53 system through ubiquitination
Yang, Y., Li, C.-C. H., & Weissman, A. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207411 · Cited by 184
p53 and NF‐κB: different strategies for responding to stress lead to a functional antagonism
Ak, P., & Levine, A. J. (2010) · The FASEB Journal · doi:10.1096/fj.10-160549 · Cited by 188
Ageing and apoptosis
Zhang, Y., & Herman, B. A. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00349-9 · Cited by 178
The ubiquitin system, disease, and drug discovery
Petroski, M. D. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s7 · Cited by 184
Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
Zhang, Y., & Xiong, Y. (2001) · PubMed · Cited by 176
Aberrant Expression of Nucleostemin Activates p53 and Induces Cell Cycle Arrest via Inhibition of MDM2
Dai, M., Sun, X., & Lu, H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01662-07 · Cited by 174
A redox mechanism underlying nucleolar stress sensing by nucleophosmin
Yang, K., Wang, M., Zhao, Y., Sun, X., Yang, Y. A., Li, X., Zhou, A., Chu, H., Zhou, H., Xu, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13599 · Cited by 178
Senescence Regulation by the p53 Protein Family
Qian, Y., & Chen, X. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-239-1_3 · Cited by 181
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Niu, Z., Jin, R., Zhang, Y., & Li, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01200-x · Cited by 185
Genotoxic and non-genotoxic pathways of p53 induction
Pluquet, O., & Hainaut, P. L. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00698-x · Cited by 177
A melanoma-associated germline mutation in exon 1β inactivates p14ARF
Rizos, H., Puig, S., Bádenas, C., Malvehy, J., Darmanian, A., Jiménez, L., Milà, M., & Kefford, R. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204728 · Cited by 171
Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kineticsPreprint
Aslanian, A., Iaquinta, P. J., Verona, R. I., & Lees, J. A. (2004) · Genes & Development · doi:10.1101/gad.1196704 · Cited by 176
Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo
Xirodimas, D., Saville, M. K., Edling, C., Lane, D. P., & Laín, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204656 · Cited by 169
A novel mammalian Smt3‐specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase
Nishida, T., Tanaka, H., & Yasuda, H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01729.x · Cited by 168
Self-citation
Versatile protein tag, SUMO: Its enzymology and biological function
Kim, K. I., Baek, S. H., & Chung, C. H. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10100 · Cited by 167
p19ARF targets certain E2F species for degradation
Martelli, F., Hamilton, T., Silver, D. P., Sharpless, N. E., Bardeesy, N. M., Rokas, M., DePinho, R. A., Livingston, D. M., & Grossman, S. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081061398 · Cited by 167
Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1
Ambrosini, G., Sambol, E. B., Carvajal, D., Vassilev, L. T., Singer, S., & Schwartz, G. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210136 · Cited by 163
High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma
Carr‐Wilkinson, J., O’Toole, K., Wood, K. M., Challen, C., Baker, A., Julian Board, Evans, L. E., Cole, M. F., Cheung, N. V., Boos, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1865 · Cited by 161
WW Domain HECT E3s Target Cbl RING Finger E3s for Proteasomal Degradation
Magnifico, A., Ettenberg, S. A., Yang, C., Mariano, J. M., Tiwari, S., Fang, S., Lipkowitz, S., & Weissman, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308009200 · Cited by 161
Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA
Kim, J.-S., Lee, C. S., Bonifant, C. L., Ressom, H. W., & Waldman, T. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00537-06 · Cited by 165
Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice
Liu, X., Chua, C. C., Gao, J., Chen, Z., Landy, C., Hamdy, R. C., & Chua, B. H. L. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00759.2003 · Cited by 162
ARF Impedes NPM/B23 Shuttling in an Mdm2-Sensitive Tumor Suppressor Pathway
Brady, S. N., Yu, Y., Maggi, L. B., & Weber, J. D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9327-9338.2004 · Cited by 163
A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control
Li, L., Liao, J., Ruland, J., Mak, T. W., & Cohen, S. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1619 · Cited by 159
Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis
Bursać, S., Brdovčak, M. C., Donati, G., & Volarević, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.014 · Cited by 166
TBX-3, the Gene Mutated in Ulnar-Mammary Syndrome, Is a Negative Regulator of p19 and Inhibits Senescence
Brummelkamp, T. R., Kortlever, R. M., Lingbeek, M., Trettel, F., MacDonald, M. E., van Lohuizen, M., & Bernards, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110492200 · Cited by 154
Adenovirus E1A: remodelling the host cell, a life or death experience
Gallimore, P. H., & Turnell, A. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204913 · Cited by 159
Molecular mechanisms of oxidative stress‐induced carcinogenesis: From epidemiology to oxygenomics
Toyokuni, S. (2008) · IUBMB Life · doi:10.1002/iub.61 · Cited by 152
Mammalian MYC Proteins and Cancer
Tansey, W. P. (2014) · New Journal of Science · doi:10.1155/2014/757534 · Cited by 166
Phosphorylation of E3 Ligase Smurf1 Switches Its Substrate Preference in Support of Axon Development
Cheng, P., Lü, H., Shelly, M., Gao, H., & Poo, M. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.021 · Cited by 150
Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Nag, S. A., Zhang, X., Srivenugopal, K. S., Wang, M.-H., Wang, W., & Zhang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/09298673113206660325 · Cited by 156
Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway
Honda, K., Mihara, H., Kato, Y., Yamaguchi, A., Tanaka, H., Yasuda, H., Furukawa, K., & Urano, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203609 · Cited by 149
Self-citation
Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
Shen, H., & Maki, C. G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795222603 · Cited by 148
Direct repression of the Mcl-1 promoter by E2F1
Croxton, R., Ma, Y., Song, L., Haura, E. B., & Cress, W. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205157 · Cited by 156
p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma
Fulci, G., Labuhn, M., Maier, D., Lachat, Y., Hausmann, O., Hegi, M. E., Janzer, R. C., Merlo, A., & Van Meir, E. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203700 · Cited by 146
Hypophosphorylation of Mdm2 Augments p53 Stability
Blattner, C., Hay, T., Meek, D. W., & Lane, D. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6170-6182.2002 · Cited by 144
Stabilization of p53 by CP-31398 Inhibits Ubiquitination without Altering Phosphorylation at Serine 15 or 20 or MDM2 Binding
Wang, W., Takimoto, R., Rastinejad, F., & El‐Deiry, W. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2171-2181.2003 · Cited by 144
Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation.
Alarcon, R. M., Koumenis, C., Geyer, R. K., Maki, C. G., & Giaccia, A. J. (1999) · PubMed · Cited by 143
Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas
Italiano, A., Bianchini, L., Gjernes, E., Keslair, F., Ranchère‐Vince, D., Dumollard, J., Haudebourg, J., Leroux, A., Mainguene, C., Terrier, P., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3185 · Cited by 142
The role of the ubiquitin/proteasome system in cellular responses to radiation
McBride, W. H., Iwamoto, K. S., Syljuåsen, R. G., Pervan, M., & Pajonk, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206676 · Cited by 145
Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity
Hegde, A. N. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.005 · Cited by 143
Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway
Horn, H. F., & Vousden, K. H. (2008) · Oncogene · doi:10.1038/onc.2008.189 · Cited by 140
A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines 1 1Edited by A. R. Fersht
Chêne, P., Fuchs, J. P., Bohn, J. A., Garcı́a-Echeverrı́a, C., Furet, P., & Fabbro, D. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3738 · Cited by 139
Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression
Suzuki, A., Sekiya, S., Büscher, D., Izpisúa Belmonte, J. C., & Taniguchi, H. (2008) · Development · doi:10.1242/dev.016634 · Cited by 136
UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts
Latonen, L., Taya, Y., & Laiho, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204883 · Cited by 134
Ribosomal Protein S6 Gene Haploinsufficiency Is Associated with Activation of a p53-Dependent Checkpoint during Gastrulation
Panić, L., Tamarut, S., Sticker-Jantscheff, M., Barkić, M., Solter, D., Uzelac, M., Grabušić, K., & Volarević, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00751-06 · Cited by 135
Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells
Fukazawa, T., Fujiwara, T., Uno, F., Teraishi, F., Kadowaki, Y., Itoshima, T., Takata, Y., Kagawa, S., Roth, J. A., Tschopp, J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204673 · Cited by 134
β-Arrestin 2 Functions as a G-Protein-coupled Receptor-activated Regulator of Oncoprotein Mdm2
Wang, P., Gao, H., Ni, Y., Wang, B., Wu, Y., Ji, L., Qin, L.-H., Ma, L., & Pei, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210350200 · Cited by 134
Modification of Cullin-1 by Ubiquitin-like Protein Nedd8 Enhances the Activity of SCFskp2 toward p27kip1
Morimoto, M., Nishida, T., Honda, R., & Yasuda, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2576 · Cited by 134
Self-citation
Nucleocytoplasmic Shuttling of p53 Is Essential for MDM2-Mediated Cytoplasmic Degradation but Not Ubiquitination
O’Keefe, K. J., Li, H., & Zhang, Y. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6396-6405.2003 · Cited by 133
p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.
Esteller, M., Cordon‐Cardo, C., Corn, P. G., Meltzer, S. J., Pohar, K. S., Watkins, D. N., Capellá, G., Peinado, M. A., Matías‐Guiu, X., Prat, J., et al. (2001) · PubMed · Cited by 132
ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus
Ries, S., & Korn, W. M. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600006 · Cited by 132
Attenuating the p53 Pathway in Human Cancers: Many Means to the Same EndPreprint
Wasylishen, A. R., & Lozano, G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026211 · Cited by 131
p53 Acetylation Is Crucial for Its Transcription-independent Proapoptotic Functions
Yamaguchi, H., Woods, N. T., Piluso, L. G., Lee, H., Chen, J., Bhalla, K. N., Monteiro, Á. N. A., Liu, X., Hung, M., & Wang, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809268200 · Cited by 131
Mdm2 haplo‐insufficiency profoundly inhibits Myc‐induced lymphomagenesis
Alt, J. R., Greiner, T. C., Cleveland, J. L., & Eischen, C. M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg133 · Cited by 129
The Corepressor mSin3a Interacts with the Proline-Rich Domain of p53 and Protects p53 from Proteasome-Mediated Degradation
Zilfou, J. T., Hoffman, W. H., Sank, M. J., George, D. L., & Murphy, M. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3974-3985.2001 · Cited by 129
Dysregulation of cellular signaling by HER2 in breast cancer
Zhou, B. P. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.006 · Cited by 127
New insights into p53 activation
Brooks, C. L., & Gu, W. (2010) · Cell Research · doi:10.1038/cr.2010.53 · Cited by 102
Cocompartmentalization of p53 and Mdm2 Is a Major Determinant for Mdm2-Mediated Degradation of p53
Xirodimas, D. P., Stephen, C. W., & Lane, D. P. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5314 · Cited by 127
The Oscar-worthy role of Myc in apoptosis
Meyer, N., Kim, S. S., & Penn, L. Z. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.011 · Cited by 132
Therapeutic exploitation of the p53 pathway
Lane, D. P., & Laı́n, S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02309-2 · Cited by 127
MDM2 and MDMX: Alone and together in regulation of p53.
Shadfan, M., Lopez-Pajares, V., & Yuan, Z.-M. (2012) · PubMed · Cited by 125
Ubiquitination by HUWE1 in tumorigenesis and beyond
Kao, S.-H., Wu, H., & Wu, K. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0470-0 · Cited by 128
Ubiquitin‐mediated control of oncogene and tumor suppressor gene products
Kitagawa, K., Kotake, Y., & Kitagawa, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01196.x · Cited by 127
Regulation of the MDM2-p53 Pathway by Ribosomal Protein L11 Involves a Post-ubiquitination Mechanism
Dai, M., Shi, D., Jin, Y., Sun, X., Zhang, Y., Grossman, S. R., & Lu, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602596200 · Cited by 124
Defining the molecular basis of Arf and Hdm2 interactions
Bothner, B. B., Lewis, W. S., DiGiammarino, E. L., Weber, J. D., Bothner, S. J., & Kriwacki, R. W. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5110 · Cited by 122
The STAT3 oncogene as a predictive marker of drug resistance
Barré, B., Vigneron, A. M., Perkins, N. D., Roninson, I. B., Gamelin, E. C., & Coqueret, O. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.001 · Cited by 123
Increased apoptosis induction by 121F mutant p53
Saller, E., Tom, E., Brunori, M., Otter, M., Estreicher, A., Mack, D. H., & Iggo, R. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4424 · Cited by 124
p53 and the Carcinogenicity of Chronic InflammationPreprint
Gudkov, A. V., & Komarova, E. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026161 · Cited by 126
Ionizing Radiation-Induced Responses in Human Cells with Differing TP53 Status
Mirzayans, R., Andrais, B., Scott, A., Wang, Y., & Murray, D. L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122409 · Cited by 127
Increased Frequency of Aberrations in the p53/MDM2/p14ARF Pathway in Neuroblastoma Cell Lines Established at Relapse
Carr, J., Bell, E., Pearson, A. D. J., Kees, U. R., Beris, H., Lunec, J., & Tweddle, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2623 · Cited by 119
The Conformationally Flexible S9–S10 Linker Region in the Core Domain of p53 Contains a Novel MDM2 Binding Site Whose Mutation Increases Ubiquitination of p53 in Vivo
Shimizu, H., Burch, L. R., Smith, A. J., Dornan, D., Wallace, M., Ball, K. L., & Hupp, T. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202296200 · Cited by 116
In Vivo Action of the HRD Ubiquitin Ligase Complex: Mechanisms of Endoplasmic Reticulum Quality Control and Sterol Regulation
Gardner, R. G., Shearer, A. G., & Hampton, R. Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4276-4291.2001 · Cited by 117
Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells
Daino, H., Matsumura, I., Takada, K., Odajima, J., Tanaka, H., Ueda, S., Shibayama, H., Ikeda, H., Hibi, M., Machii, T., et al. (2000) · Blood · doi:10.1182/blood.v95.8.2577 · Cited by 115
Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells
Wang, J., Sampath, A., Raychaudhuri, P., & Bagchi, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204655 · Cited by 115
Cells Degrade a Novel Inhibitor of Differentiation with E1A-Like Properties upon Exiting the Cell Cycle
Miyake, S., Sellers, W. R., Safran, M., Li, X., Zhao, W., Grossman, S. R., Gan, J., DeCaprio, J. A., Adams, P. D., & Kaelin, W. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8889-8902.2000 · Cited by 112
HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication
Izumi, T., Io, K., Matsui, M., Shirakawa, K., Shinohara, M., Nagai, Y., Kawahara, M., Kobayashi, M., Kondoh, H., Misawa, N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008076107 · Cited by 109
LncRNA Meg3 protects endothelial function by regulating the DNA damage response
Ali, M. S. S. H., Cheng, X., Moran, M., Haemmig, S., Naldrett, M. J., Alvarez, S., Feinberg, M. W., & Sun, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1190 · Cited by 113
Regulation of p53 Stability and Function in HCT116 Colon Cancer Cells
Kaeser, M. D., Kaeser-Pebernard, S., & Iggo, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311732200 · Cited by 113
Myc-ARF (Alternate Reading Frame) Interaction Inhibits the Functions of Myc
Datta, A., Nag, A., Pan, W., Hay, N., Gartel, A. L., Colamonici, O. R., Mori, Y., & Raychaudhuri, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312305200 · Cited by 113
Insulin-like Growth Factor I Induces MDM2-dependent Degradation of p53 via the p38 MAPK Pathway in Response to DNA Damage
Héron‐Milhavet, L., & LeRoith, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111142200 · Cited by 114
West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus
Yang, M.-R., Lee, S. R., Oh, W., Lee, E., Yeh, J., Nah, J., Joo, Y.-S., Shin, J., Lee, H., Pyo, S., et al. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01027.x · Cited by 113
Mutations in the INK4a/ARF Melanoma Susceptibility Locus Functionally Impair p14ARF
Rizos, H., Darmanian, A., Holland, E. A., Mann, G. J., & Kefford, R. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105299200 · Cited by 113
Identification of Three Functions of the Adenovirus E4orf6 Protein That Mediate p53 Degradation by the E4orf6-E1B55K Complex
Querido, E., Morrison, M. R., Dang, H. C. P., Thirlwell, S. W.-L., Boivin, D., & Branton, P. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.699-709.2001 · Cited by 110
ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization
Korgaonkar, C. K., Zhao, L., Modestou, M., & Quelle, D. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.196-206.2002 · Cited by 111
DNA Damage Disrupts the p14ARF-B23(Nucleophosmin) Interaction and Triggers a Transient Subnuclear Redistribution of p14ARF
Lee, C., Smith, B. A., Bandyopadhyay, K., & Gjerset, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1759 · Cited by 106

Authors: Honda, R., & Yasuda, H.
Affiliations: Tokyo University of Pharmacy and Life Sciences (JP)
Corresponding author: Yasuda, Hideyo
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 1999-01-04
Volume: 18
Issue: 1
Pages: 22-27
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1093/emboj/18.1.22
PMC: PMC1171098
OpenAlex: W2028210102
Cited by: 724
References: 43
Citations by year: 2026: 1 · 2025: 3 · 2024: 3 · 2023: 12 · 2022: 12 · 2021: 3 · 2020: 10 · 2019: 4 · 2018: 11 · 2017: 5 · 2016: 14 · 2015: 19 · 2014: 20 · 2013: 24 · 2012: 20
FWCI: 33.88
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: European Molecular Biology Organization
Institute of Genetics
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords: p19ARF, MDM2, p53, ubiquitin ligase activity, p53 ubiquitination, p53 stabilization, DNA-dependent protein kinase, p53 phosphorylation, DNA damage response, tumor suppressor proteins, protein-protein interaction
MeSH terms: Animals, Cell Line, Cloning, Molecular, DNA-Binding Proteins, HeLa Cells, Humans, Ligases, Mutation, Nuclear Proteins, Phosphorylation, Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Ubiquitins, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Spodoptera, Tumor Suppressor Protein p14ARF, Ubiquitin-Protein Ligases, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks